ImmunoGen, Inc.
immunogen.comLicenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
Rate This Site
Embed Badge
Place this code on your website to show you're listed here.